CAR T-Cell Therapy

CAR T-cell therapy is an advanced form of immunotherapy that turns a patient's own immune cells into a living treatment for blood cancers such as multiple myeloma. A type of white blood cell called the T-cell is collected from the patient, sent to a specialist laboratory and genetically reprogrammed to recognise and attack the cancer, then grown in large numbers and given back as a single infusion. Because the treatment uses the body's own cells that have been taught to seek out the disease, it can work against leukaemia, lymphoma and myeloma that have come back or no longer respond to standard drugs. It is a complex, highly specialised treatment delivered only in experienced centres, which is why many people travel abroad to reach a unit with the laboratory links, the trained team and the intensive support that CAR T-cell therapy requires. The path involves several steps over a number of weeks, so understanding the timeline, the in-hospital monitoring and how follow-up continues at home is as important as the science itself.